Hepatocellular carcinoma with worsened hypoglycemia after transarterial chemoembolization: a case report and systematic review.
Lists
Only you see this
Abstract
Non-islet cell tumor hypoglycemia (NICTH) is an extremely uncommon and serious complication of hepatocellular carcinoma (HCC). Here, we reported a case of a 47-year-old male patient with moderate to poorly differentiated HCC complicated by hypoglycemia that worsened after transarterial chemoembolization (TACE). The patient was admitted into The First Affiliated Hospital of Naval Medical University due to fatigue, nausea, dizziness and passage of tea colored urine. He was diagnosed with NICTH induced by HCC according to CT scanning and laboratory tests. TACE was used as the primary therapy but the hypoglycemia worsened afterward. Then the patient received a liver transplantation as a possible radical cure and hypoglycemia was resolved. We systematically review the management of hypoglycemia caused by HCC and the results show that patients undergoing treatment that mainly alleviate tumor burdens obtained a significantly higher response rate than patients undergoing therapies mainly regulating biologic functions (50.0% vs 27.3%). Cytoreductive surgery, TACE and radiotherapy which aimed to alleviate tumor burdens are effective therapies have great potential, but the risk of hypoglycemic deterioration requires particular attention when using these treatments, especially with TACE.
BibTeX
@inproceedings{yu2020hepatocellular,
author = {Jiao Yu and Xue-Song Liang and Yi Chen and Feihu Huang and Wenhan Fan and Jianya Xue and Chengzhong Li},
title = {{Hepatocellular carcinoma with worsened hypoglycemia after transarterial chemoembolization: a case report and systematic review.}},
booktitle = {PubMed},
year = {2020},
}Loading related content...